8. Substance dependence
8.1 Alcohol dependence
Alcohol dependence | Preparations | Comments |
The drugs listed below are for the acute/initial management of alcohol dependence and withdrawal. For longer term management and relapse prevention service users should be referred to CDAT service run by CRI. | ||
Chlordiazepoxide | 5mg capsules or tablets | See chlordiazepoxide for alcohol withdrawal regime |
Thiamine | 50mg and 100mg tablets | |
Vitamin B Co strong | Tablets | |
High potency vitamin B complex (Pabrinex) |
DISCONTINUED IM injection |
For in-patient use. Facilities for treating anaphylaxis (including resuscitation facilities should be available when parenteral thiamine is administered. |
8.2 Nicotine dependence
Nicotine dependence | Preparations | Comments |
Nicotine | Transdermal patch: Nicorette® Inivsi Patches 25mg, 15mg and 10mg Lozenges:NiQuitin® Minis Lozenges 1.5mg and 4mg Inhalation vapour: Nicorette® Inhalator 15mg cartridgesOrodispersible film (strips): NiQuitin® 2.5mg oral filmSublingual tablet: Nicorette® Microtab 2mgNasal spray: Nicorette® 500 microgram per actuationMouth spray: Nicorette® Quickmist 1mg per actuation |
See HPFT Nicotine Replacement Therapy Policy for Inpatients |
Varenicline tartrate | 500microgram and 1mg tablet. | NICE -TA123 - Varenicline for smoking cessation Named patient request only |
8.3 Opioid dependence
Opioid dependence | Preparations | Comments |
Treatment of opioid dependence usually requires specialist intervention - generalists who do not have specialist experience should contact Community drugs and alcohol services (CGL) for advice before attempting to treat opioid dependence. NICE -TA114 - Methadone and buprenorphine for the management of opioid dependence |
||
Buprenorphine hydrochloride |
400microgram, 2mg and 8mg sublingual tablets 2mg and 8mg oral lyophilisate tablets (Espranor) |
CD. Only in accordance with specialist recommendations. |
Methadone hydrochloride | 1mg/ml SF oral solution | CD. Only in accordance with specialist recommendations. |